Welcome to the Annie Appleseed Project! There are so many simple steps that can be taken to increase your chances of surviving and beating cancer. We want to help you make more informed treatment decisions. Read More
GET UPDATES
BY EMAIL
Information by Cancer Types
In this section you will continue to find information on specific cancer types. Lots of articles, abstracts, etc. are stored in our Archive section as well - linked from and to each type of cancer covered. We'll try to bring in new information often. The basics stay the same. Eat more fruits and vegetables, get some exercise (move about at a minimum), relax a little every day, take some useful supplements like fish oil, curcumin and probiotics, and think about detoxing from exposure to the chemical soup that is our world.
We answer ALL emails.
We have a handout we can supply via email that speaks to a variety of natural therapies and substances almost anyone can use to help reduce toxicities. Find out about them BEFORE treatment starts if you can. Our FREE gift to you - Handout Natural Strategies to Reduce Toxicities Share widely with anyone undergoing or recovering from conventional treatments. If printed, please use double-sided to save paper.
Also see Alternative Medicine section, Studies on nutrition, exercise, dietary supplements (more), Cancer Clinics around the world - we have lots more information available.
Please look at our section on Studies for Nutrition, Dietary Supplements, Exercise and MORE.
Special note: New evidence now states that people can drink CLEAR liquids up to 2 hours before surgery. This goes for children as well. If your hospital is not up to date on this, tell them to look at this information Evidence-Based Child Health: A Cochrane Review Journal Volume 1, Issue 1 , Pages 166 - 280 May 2006 This was discussed in the New York Times Q&A Science section on November 28, 2011 confirming that it was safe for adults to drink CLEAR liquids (FYI milk is NOT a clear liquid).
An important announcement from 2007.
FDA News, December 2007:
New Safety Concerns On ESAs Prompt FDA To Consult ODAC
By Paul Goldberg
The Cancer Letter, volume 34, no 1
Two studies pointing to increased mortality and disease progression from erythropoiesis-stimulating agents will cause FDA to seek guidance from an advisory committee, the agency announced. Initially, the agency communicated its plans to the sponsors, who are obligated to share such development with the public (The Cancer Letter, Dec. 7, 2007).
Then, on Jan. 3, FDA issued a press release stating that the most recent studies amplify the safety concerns observed in six studies now listed on the ESA label. "Taken together, all eight studies show more rapid tumor growth or shortened survival when patients with breast, non-small cell lung, head and neck, lymphoid or cervical cancers received ESAs compared to patients who did not receive this treatment.
In all of these recent studies, ESAs were administered in an attempt to achieve a hemoglobin level of 12 g/dL or greater, although many patients did not reach that level," the agency said in a statement.
NOTE: A recent page produced by the Centers for Disease Control (CDC) does NOT mention ESAs when talking about the "best ways to prevent infections" while undergoing chemotherapy. April 2012
Information by Cancer Type - find link to Archived material and new - Please NOTE we cannot change anything in the Archives
Head and Neck Cancers *** Video of Ann Fonfa addressing this issue and cancer support
Kidney Cancer (Renal)
Lung Cancer (including Mesothelioma)
Occular (Eye)
Ovarian and Gyn Cancers
Skin Cancer (including Melanoma)
Remember: We are NOT Doctors and have NO medical training.
DISCLAIMER: The information provided is for educational purposes only. It is not meant to diagnose or treat any health condition and is not a replacement for treatment by a healthcare provider.
This article or site may contain copyrighted material, the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of health, political, human rights, economic, democratic, and social justice issues, etc. We believe this constitutes a "fair use" of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed an interest in receiving the included information for research and educational purposes. For more information go to: Cornell University Law School.
This site complies with the HONcode standard for trustworthy health information:
verify here.